PMS2 and neoplasm: Interestingly, most of PMS2 PV carriers showed, beyond CRC, some cases of associated breast cancer, supporting the recent hypothesis that this neoplasm could also be included in the LS tumor spectrum, as already highlighted by other studies (35–39).